New Drug Manufacturing Plant Set to Transform Pharma Landscape

This chapter discusses the imminent launch of a $3 billion drug manufacturing plant in North Carolina, coinciding with favorable changes in U.S. trade policy affecting pharmaceutical tariffs. It also features a live update from a microbiology lab within the facility, detailing the stringent quality control measures being implemented by leading pharmaceutical companies.